Core Points - The first three newly registered companies in the Sci-Tech Innovation Board's growth tier were listed on October 28 at the Shanghai Stock Exchange [1][3] - These companies, Wuhan Heyuan Biotechnology Co., Ltd., Xi'an Yisiwei Material Technology Co., Ltd., and Guangzhou Bibete Pharmaceutical Co., Ltd., are all in the unprofitable stage and have entered the growth tier of the Sci-Tech Innovation Board [3][5] - The growth tier is designed for technology companies with significant breakthroughs, broad commercial prospects, and substantial ongoing R&D investments [3] Industry Developments - The China Securities Regulatory Commission (CSRC) has introduced significant policy measures, including the "Eight Articles for the Sci-Tech Innovation Board" and "Six Articles for Mergers and Acquisitions," to support the growth of the Sci-Tech Innovation Board [5] - The implementation of the "1+6" reform in June has progressed smoothly, establishing the growth tier and introducing pilot programs for professional institutional investors and pre-review systems [5] - The Sci-Tech Innovation Board has become the preferred venue for domestic "hard technology" companies, supporting the listing of 592 companies in high-tech and strategic emerging industries, with a total market capitalization exceeding 9 trillion yuan [6]
媒体视角 | 科创板科创成长层首批新注册企业上市
Sou Hu Cai Jing·2025-10-29 01:05